2
项与 177Lu-DOTA-ABM-5G 相关的临床试验Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
This is a Phase I study to evaluate the safety and efficacy of the [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G theranostics pair in patients with metastatic non small cell lung cancer (NSCLC).
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
This is a Phase I, first-in-human study to evaluate the safety and efficacy of the [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G theranostic pair in patients with locally advanced or metastatic pancreatic adenocarcinoma (PDAC).
100 项与 177Lu-DOTA-ABM-5G 相关的临床结果
100 项与 177Lu-DOTA-ABM-5G 相关的转化医学
100 项与 177Lu-DOTA-ABM-5G 相关的专利(医药)
100 项与 177Lu-DOTA-ABM-5G 相关的药物交易